Drug Delivery refers to dosage form, route of administration, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via the biopharmaceutical or small molecule drug's formulation, but it may also involve medical devices or drug-device combination products. Considerations include instrumentation, software and services.
Recombinant albumin developed as an excipient for use in drug delivery and formulation. Recombumin Prime is the world's first and only supply of commercial, animal-free, recombinant human albumin, approved for use in the manufacture of human therapeutics.Used in the manufacture of the FDA and EMEA approved MMR™ II childhood vaccine from Merck and Co., Recombumin Prime USP-NF* is also being evaluated as an excipient, or ingred…
Derived from our proprietary S. cerevisiae yeast expression technology Recombumin Alpha USP-NF* has been developed to deliver quality and unprecedented performance benefits in our customers' applications including drug and vaccine manufacture, device coating, IVF media, specialized cell culture and cell therapy applications. Benefits: Animal-free Secure supply in large volume quantities cGMP for regulatory-compliance…
The cornerstone of all vaccine development efforts at Immunovaccine is the company’s DepoVax™ vaccine adjuvanting platform. DepoVax is a patented vaccine delivery formulation that provides controlled and prolonged exposure of antigens plus adjuvant to the immune system. The result is a strong, specific and sustained immune response with the capability for single-dose effectiveness.The DepoVax platform possesses impressive fle…
The IntelliCap system may be used for delivery of a drug or therapuetic agent to a targeted location. The capsule contains a fluid reservoir and a micro-fluidic pump capable of pumping fluids, pastes or suspensions. Operation of the pump is controlled by an integrated microprocessor. The IntelliCap also contains sensors that measure the pH and temperature of the pill’s local environment and an ultra-low power radio transceive…
Fast pre- and fine-grinding in one instrument
Fast, contamination free grinding below 1 micron. Handles sample volumes from 1 ml up to 4 x 225 ml.
In contrast to conventional Planetary Mills, the rotational speed of the grinding bowls and supporting disk can be configured separately in the Vario-Planetary Mill PULVERISETTE 4 classic line with 2 working stations. Your advantage: A single mill for mechanical activating and alloying providing optimum grinding conditions suited to the respective material to be ground and the size of the grinding bowls and balls! For resul…
Fast analysis of particle shape and size of powders and bulk solids!
Our HybridSPE ® -PLus plates effectively remove phospholipids and proteins from biological matrices in a simple pass-through method for accurate and reproducible LC-MS analysis. Unlike other phospholipid removal SPE products on the market, the unique retention mechanism of HybridSPE ® allows for separation of even very hydrophobic analytes from phospholipid contaminants.
Supel™ Swift HLB is a polymeric stationary phase for solid phase extraction (SPE) prior to instrumental analysis. It has both hydrophilic and lipophilic functional groups for the extraction of a broad range of compounds from aqueous samples. It retains analytes having diff erent polarities and Log P values due to its hydrophilic and lipophilic balance (HLB) property.
Charles River is a preclinical drug discovery CRO that manages your project from drug target discovery to hit identification, hit-to-lead, and lead optimization
NanoXact Mesoporous Silica Nanospheres - 100 nm, 5 mg/mL in ethanol
NanoXact Mesoporous Silica Nanospheres - (Dried) - 100 nm
The Ustekinumab ELISA kit is intended for the quantitative determination of Ustekinumab in serum, plasma and cell culture samples.
The Adalimumab (Humira) ELISA kit is intended for the quantitative determination of Adalimumab (Humira) in serum, plasma and cell culture samples. CE IVD marked. Calibrated against NIBSC International Standards from WHO (17/236).
The Eculizumab ELISA kit is intended for the quantitative determination of Eculizumab in serum, plasma and cell culture samples.
This Degarelix ELISA kit is intended for the quantitative determination of Degarelix in serum, plasma and cell culture samples.
Immunoassay for quantitative estimation of Teriparatide in human serum and plasma.
The Tocilizumab ELISA kit is intended for the quantitative determination of Tocilizumab in serum, plasma and cell culture samples.
The Natalizumab ELISA kit is an assay intended for the quantitative determination of Natalizumab in serum, plasma and cell culture samples.
The Vedolizumab ELISA kit is intended for the quantitative determination of Vedolizumab in serum, plasma and cell culture samples.
The Daratumumab (Darzalex) ELISA kit is an assay intended for the quantitative determination of Daratumumab (Darzalex) in serum, plasma and cell culture samples.
The Pembrolizumab ELISA kit is intended for the quantitative determination of Pembrolizumab in serum, plasma and cell culture samples. RUO only.
ELISA for the quantitative determination of Leuprolide / Leuprorelin in serum and plasma.
